Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Abraxane and Gemcitabine Followed by Chemoradiation for Pancreatic Cancer
NCT02427841Phase 2Completed
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Jan 2016
- Primary completion
- Nov 2019
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in pancreatic adenocarcinoma (PDAC), sponsored by OHSU Knight Cancer Institute. Started Jan 2016; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02427841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02427841.